Abstract:Objectives: To analyze the results of neonatal screening for congenital hypothyroidism (CH) and hyperphenylalaninemia (HPA) in Zhejiang province from 1999 to 2022. Methods: A total of 11 922 318 newborns were screened from September 1999 and December 2022 in Zhejiang province. The blood thyroid stimulating hormone (TSH) levels were measured by a fluorescence method and blood phenylalanine (Phe) levels were measured by fluorescence method or tandem mass spectrometry. TSH≥9 μIU/mL was considered positive for CH, while Phe>120 μmol/L and/or Phe/Tyr ratio>2.0 were considered positive for HPA. The positive newborns in screening were recalled, and the gene variations were detected by high-throughput sequencing and MassARRAY tests. Results: The overall neonatal screening rate during 1999-2022 was 89.41% (11 922 318/13 333 929) and the screening rate was increased from 6.46% in 1999 to 100.0% in 2022. A total of 8924 cases of CH were diagnosed among screened newborns with an incidence rate of 1/1336. A total of 563 cases of HPA were diagnosed, including 508 cases of classic phenylketonuria (cPKU) and 55 cases of tetrahydrobiopterin deficiency (BH4D), with an incidence rate of 1/21 176. Ninety-seven out of 8924 cases of CH underwent genetic analysis. Gene mutations were detected in 9 CH related genes, the highest frequency mutations were found in DUOX2 gene (69.0%) with c.3329G>A (p.R1110Q) (18.2%) and c.1588A>T (p.K530X) (17.3%) as the hotspot mutations. There were 81 PAH gene variants detected in a total of 250 cases of cPKU, and c728G>A (p.R243Q) (24.4%), c.721C>T (p.R241C) (15.0%) were the hotspot mutations. Meanwhile 7 novel variants in PAH gene were detected: c.107C>A (p.S36*), c.137G>T (p.G46V), c.148A>G(p.K50E), c.285C>T (p.I95I), c.843-10delTTCC, exon4-7del and c.1066-2A>G. There were 12 PTS gene variants detected in 36 cases of BH4D, and c.259C>T (p.P87S) (31.9%) was the hotspot mutation. Conclusions: The incident of CH has increased from 1999 to 2022 in Zhejiang province, and it is higher than that of national and global levels; while the incidence of HPA is similar to the national average. DUOX2 gene variation is the most common in CH patients; c.728G>A (p.R243Q) is the hotspot mutation in cPKU patients, while c.259C>T (p.P87S) is the hotspot mutation in BH4D patients.

Newborn Screening in Zhejiang, China

Neonatal screening for congenital hypothyroidism and phenylketonuria in China

[Retrospective Study on Neonatal Screening for Congenital Hypothyroidism and Phenylketonuria in China in the Past 22 Years].

Screening for congenital hypothyroidism in neonates of Zhejiang Province during 1999-2004]

Screening for phenylketonuria in 726,998 neonates in Zhejiang Province]

Study of the Administrative Approach of Newborns Screening in Zhejiang Province

A Multicenter Prospective Study of Next-Generation Sequencing-Based Newborn Screening for Monogenic Genetic Diseases in China

Newborn screening in China: phenylketonuria, congenital hypothyroidism and expanded screening.

[Screening for Fatty Acid Oxidation Disorders of Newborns in Zhejiang Province:Prevalence, Outcome and Follow-Up].

Newborn Screening for Inborn Errors of Metabolism in Mainland China: 30 Years of Experience.

Pitfalls in the Management of Phenylketonuria in China

[Screening for Phenylketonuria and Congenital Hypothyroidism in 5.8 Million Neonates in China].

[Screening for neonatal inborn errors of metabolism by electrospray ionization-tandem mass spectrometry and follow-up].

Diagnosis and treatment of subclinical hypothyroidism detected by neonatal screening

Indicators of Child Health, Service Utilization and Mortality in Zhejiang Province of China, 1998-2011

Preliminary Application of Region 4 Stork Project Used in Newborn Screening by Tandem Mass Spectrometry

Problems and reflection on the screening and diagnosis for disease of newborn

Progress of newborn screening in China

Neonatal Screening for Congenital Hypothyroidism and Phenylketonuria in Chengdu from 1992 to 2010

Results of neonatal screening for congenital hypothyroidism and hyperphenylalaninemia in Zhejiang province from 1999 to 2022

A Clinical Investigation of 228 Patients with Phenylketonuria in Mainland China.